UNSPSC 51271623: Bupivacaine hydrochloride monohydrate

This classification denotes an anesthetic agent with the molecular formula C18H28N2O.ClH.H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 7TQO7W3VT8, chemically known as 2-piperidinecarboxamide, 1-butyl-n-(2,6-dimethylphenyl)-, monohydrochloride, monohydrate, but more generally known as bupivacaine hydrochloride monohydrate, which bears US NIH Compound Identifier 64737.

European Medicines Agency schedules bupivacaine hydrochloride monohydrate or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05983MIG. Most nations, for tariff purposes, schedule bupivacaine hydrochloride monohydrate under HS 29333999. SMILES: CCCCN1CCCCC1C(=O)NC2C(CCCC2C)C.O.CL.

UNSPSC 51271623 Bupivacaine hydrochloride monohydrate is a Commodity code for a local anesthetic pharmaceutical used in surgical and procedural settings. State and local governments procure this injectable medication primarily through health departments, public hospital systems, surgical centers, and emergency medical services. The drug is a long-acting local anesthetic commonly used for infiltration anesthesia, nerve blocks, and spinal anesthesia in both routine and emergency procedures. Purchasing is typically driven by clinical demand, formulary adoption, and standardized procurement protocols within public health systems rather than by episodic solicitation cycles.

The source provided contains no recent state and local contract opportunities under this code.